Twist Bioscience Corporation TWST Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's investing cash flow?
- Twist Bioscience Corporation (TWST) reported investing cash flow of -$12.71M in Q1 2026.
- How has Twist Bioscience Corporation's investing cash flow changed year-over-year?
- Twist Bioscience Corporation's investing cash flow decreased by 791.0% year-over-year, from -$1.43M to -$12.71M.
- What is the long-term trend for Twist Bioscience Corporation's investing cash flow?
- Over 3 years (2021 to 2025), Twist Bioscience Corporation's investing cash flow has grown at a -45.9% compound annual growth rate (CAGR), from $156.16M to -$24.76M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.